Cinotti, Elisa

Damiani, Francesco

Marcolongo, Paola

Mariotti, Giancarlo

Marrocco, Camilla

Pellegrino, Michele

Rubegni, Pietro

Tognetti, Linda

Trovato, Emanuele

English

PubMed

Archivio della Ricerca - Università degli Studi di Siena

Photodermatol Photoimmunol Photomed. 2022;38:391–394.    |  391wileyonlinelibrary.com/journal/phppReceived: 16 June 2021  |  Revised: 29 October 2021  |  Accepted: 4 November 2021DOI: 10.1111/phpp.12752  L E T T E REvaluation of 11- β hydroxysteroid dehydrogenase type 1 in cutaneous fibroblasts cultures of psoriatic lesional skin before and after narrow band- UVB phototherapyDear Editor,The endogenous glucocorticoid (eGC) group include those mol-ecules, similar to exogenous synthetic ones in terms of chemical structure, which are synthesized in the human body: the largest amount is produced by the adrenal cortex and the rest by the skin, with a slower process. The known eCG effects in the skin include epidermal thinning, melanogenesis impairment, inflammation sup-pression and erythema reduction.1,2Cortisol is the most important among eGCs, and its availability depends on the pre- receptorial regulation of the 11β- hydroxysteroid dehydrogenase (HSD) enzymes, that is 11β- HSD1 (converts corti-sone to the active form, cortisol) and 11β- HSD2 (catalyses the op-posite reaction).1- 3 Over the last years, the role of 11β- HSD1 as a key regulator of eGC activity was investigated in several tissues (eg ovary, placenta, lung, central nervous system, adipose tissue, liver, colon and kidney).1,4 Of note, it was recently identified in the epider-mis and the dermis,3- 6 particularly in keratinocytes,6 fibroblasts4 and endothelial cells.5Psoriasis is an inflammatory disease characterized by a chronic- relapsing course and a rapid response to topical application of ex-ogenous glucocorticoids. The nbUVB phototherapy 311 nm is also effective in mild- to- moderate psoriasis, but its exact mechanism of action on psoriatic skin is yet to be fully elucidated.On these premises, we aimed to investigate the modifications in 11β- HSD1 expression in psoriatic lesions of patients after treatment with nbUVB phototherapy.A total of 10 psoriatic patients with average PASI (Psoriasis Area and Severity Index) = 9.6 (Table 1) were recruited in the Phototherapy Unit of the Dermatology Department of Siena University Hospital: they gave signed, informed consent after re-ceiving written and oral information on the study. The study was car-ried out between September 2015 and December 2019, approved by the local ethics committee and conducted according to Helsinki Declaration ethical conditions. Inclusion criteria were as follows: age >18 years; mild (PASI<7) and moderate (PASI 7- 17) plaque psoriasis7; presence of a psoriatic plaque of at least 5 cm in diameter within a photo- protected area (ie the medial surfaces of the forearm/arm/tights/bottom or side) which can be selected for skin biopsy; and having patient's commitment not to expose to the sun/not to apply topical corticosteroid preparations on the selected plaque for the whole duration of the study (Table 1). At baseline, a 6- mm punch bi-opsy was performed from the lesional margin of a selected psoriatic plaque, for histopathological examination and human cell cultures set up; 2 weeks after the last phototherapy session, a second bi-opsy was done 3- 5 mm distant from the scar point (Figure 1A). All patients performed standard protocol of nbUVB doses (from 500 to 1300 mj/cm2) of 3 sessions/week (total 24 consecutive sessions) from October to April. A whole- body irradiation was performed with GP24H medical bed, Cosmedico®, Medizintechnik; patients wore protective sunglasses during all sessions. Patients were followed up every 3 months for 1 year. Control healthy skin samples were pro-cured from 20 healthy patients aged 25- 65 undergoing dermatologic surgery for benign lesions, matched for age, sex and body site.Human lesional fibroblasts were isolated from a skin biopsy and cultured in DMEM (Dulbecco's modified Eagle's medium, Sigma- Aldrich), 10% FBS (fetal bovine serum, Euroclone), 5 mM penicillin/streptomycin (Euroclone) and 2 mM L- glutamine (Euroclone) in an in-cubator at 37°C. From each sample, total RNA was extracted using NucleoSpin RNA kit (Macherey- Nagel), according to the manufac-turers’ instructions. cDNA was prepared from 500 ng RNA using the SuperScript III First- Strand Synthesis SuperMix for qRT- PCR kit (Invitrogen by Life Technologies). Experiments were done with the RT- PCR protocol of the manufacturer of TransStart Top Green qPCR SuperMix (Transgen Biotech, China). Target gene 11β- HSD1 expression was normalized using GAPDH, and the expression in each sample was calculated relative to the average of control samples, using the 2−ΔΔct method analysis. qRT- PCR analysis was performed on MJ Research PTC- 200 (Bio- Rad). For proteins analysis, fibroblasts were lysed by a Lysis Buffer (LB) (20 mM Tris- HCl, 135 mM NaCl, 10% glycerol, 1% Nonidet P- 40, 10 mM EDTA, pH 8, with proteases inhibitor cocktail (Thermo Scientific). Protein concentration was quantified by using QuantumMicroProtein (EuroClone). Samples were separated by SDS- PAGE (Precast gel Bolt 4%- 12% Bis- Tris Plus, Invitrogen by Thermo Fisher Scientific) and then transferred to a nitrocellulose membrane (GE Healthcare by Life Science) in order to detect 11β- HSD1 protein. Membranes were incubated overnight at 4°C with anti- 11β- HSD1 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.© 2021 The Authors. Photodermatology, Photoimmunology & Photomedicine published by John Wiley & Sons Ltd.392  |     LETTER TO THE EDITOR antibody 1:200 (Polyclonal Antibody, Cayman Chemical) and mono-clonal anti- α tubulin antibody (GeneTex), used as a quantification control. Bands were detected by 1- hour incubation with secondary antibodies 1:1000 (Anti- rabbit IgG HRP- linked antibody, Cell Signaling), and they were finally analysed by ChemiDoc (Bio- Rad).One month after last phototherapy session (time 7), average PASI was 3.8, with relevant improvement on the biopsy site (Figure 1B, Table S1). The average 11β- HSD1 mRNA expression values obtained from all analysed samples are reported in Figure 1C: in psoriatic pa-tients, 11β- HSD1 levels were lower at baseline compared with control subjects, but significantly increased r (P = .0015) after nbUVB treat-ment. Western blot analysis (Figure 1D) confirmed the mRNA results showing a 34- KDa immunoreactive band evident in all samples, with decreasing levels of intensity from post to Ctrl to pre. Normalization TA B L E  1   Patients’ characteristics at baseline and follow- up timesPatient Age Sex BMI PhototypeDisease duration (months)Biopsied plaque area PASI(cm2) baseline time 3 time 71 51 F 23 III 24 140 10 6 42 47 M 24 III 36 200 12 8 63 36 M 22 II 8 90 7 4 24 41 F 24 III 18 130 8 5 25 57 M 25 III 21 240 9 6 36 25 F 22 III 10 80 9 5 27 43 M 24 II 30 110 11 8 48 33 M 22 III 6 90 9 7 49 45 F 24 III 28 160 10 10 610 65 M 25 III 32 180 11 9 5Note: time 3 = 1 month after last phototherapy session; time 7 = 3 months after last phototherapy sessionF I G U R E  1   A 41- year- old man with moderate plaque psoriasis: clinical appearance at baseline (A) with a PASI of 13, 4 and (B) 1 mo after the last phototherapy session, with a PASI of 3. Black circles with continue line, correspond to the body site biopsied for histological analysis and setting of the skin cultures. Dotted line circle identifies the baseline biopsy site and dotted line the margin of the psoriatic plaque. Levels of mRNA relative expression of 11β- HSD1 detected in human cultures of healthy fibroblasts (Ctr), of lesional fibroblasts isolated from a psoriatic plaque before (Pre) and after treatment (Post) (C). Western blot analysis of 11β- HSD1 showing a 34 kDa protein (D), along with tubulin, was immunodetection for loading control(A) (B) (C)(D)     |  393LETTER TO THE EDITOR through α- tubulin is also shown. No statistically significant difference was observed between PASI<7 and PASI 7- 12 patients.Psoriasis is a frequent skin disease with reported prevalence ranges between 0.09% and 11.43%, with at least 100 million indi-viduals affected worldwide.7 Its aetiology is multifactorial, and the molecular alterations at tissue levels are complex and still not fully understood.8 In particular, few data are available about the specific role of the skin cutaneous glucocorticoid homeostasis in the devel-opment of psoriasis.1,2,8 Nevertheless, investigating the steroids skin metabolism represents a crucial step to understand the physiopathol-ogy of the disease and the therapeutic response of psoriatic plaque to both topical CG treatments and nbUVB irradiation. Indeed, previous investigations of Slomisnki et al on the regulatory networks of skin steroidogenesis suggested that some key pathways can be crucial to understand the physiopathological tissue mechanisms underlying several inflammatory skin diseases.1,9,10 In particular, UVB rays ap-peared to be able to elicit, more efficiently than UVA, the tissue pro-duction of multiple molecules (eg cytokines, corticotropin- releasing hormone and proopiomelanocortin- peptides), that can further regu-late neuroendocrine central hypothalamic- pituitary- adrenal axis axes after released into circulation.10 To date, a higher expression of 11β- HSD1 was detected in UVB and UVA exposed skin in murine mod-els,11,12 while an reduced eCGs synthesis was found skin.8Here, in this study, we demonstrated the key role of 11β- HSD1 enzyme in psoriatic human skin treated with nbUVB photother-apy. Firstly, we observed that 11β- HSD1 is constitutionally down- expressed in lesional psoriatic skin, causing a reduced availability of the cortisol active form and suggesting that a relevant impairment in local steroidogenesis occurs in these patients. This finding is in line with a reduced expression of the steroidogenesis promoter CCHR1 gene detected in human keratinocyte cultures, derived from untreated psoriatic plaques, reported by Tiala et al8 Secondly, we demonstrated that the nbUVB phototherapy is able to induce either a normalization and a significant increase in the 11β- HSD1 levels (ie 4- time fold) compared with baseline cells and healthy controls cells, respectively. This direct effect of nbUVB on psoriatic keratinocytes and fibroblasts is likely to determine a larger availability of endog-enous cortisol at tissue level that can explain, at least partially, the beneficial effects of the nbUVB at clinical level, in line with the over-mentioned in vitro experiments.9- 12 Moreover, the present findings can explain the higher durability of nbUVB effects in time compared with the anti- inflammatory effects exerted by the topical application of exogenous CG ointments.In this context, the possibility to enhance the eGC production is of paramount importance in the management of chronic- relapsing psoriasis and spare the collateral effects of exogenous CGs. Further studies are, however, needed to confirm the present find-ings, adding parallel investigations on the glucocorticoid receptor expression before and after phototherapy on psoriatic and normal keratinocytes.KE Y WORDSnbUVB phototherapy, plaque psoriasis, human skin cultures, 11β- HSD1ACKNOWLEDG MENTSOpen Access Funding provided by Universita degli Studi di Siena within the CRUI-CARE Agreement. [Correction added on 19 May 2022, after first online publication: CRUI-CARE funding statement had been added.]CONFLIC T OF INTERE S TNone.DATA AVAIL ABILIT Y S TATEMENTThe data that support the findings of this study are available from the corresponding author upon reasonable request.Linda Tognetti1Francesco Damiani2Camilla Marrocco1Giancarlo Mariotti1Emanuele Trovato1Elisa Cinotti1Paola Marcolongo2Michele Pellegrino3Pietro Rubegni11Department of Clinical, Dermatology Unit and Skin Bank Unit, Surgical and Neurosciences, University of Siena, Siena, Italy2Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy3Dermatology Unit, Misericordia Hospital, Grosseto, ItalyCorrespondenceL. Tognetti, Department of Dermatology - Division of Medical, Surgical and Neurosciences, University of Siena, Le Scotte Hospital, Viale Bracci 16, 53100 Siena, Italy.Email: l.tognetti@student.unisi.itORCIDLinda Tognetti  https://orcid.org/0000-0002-6691-4310 Emanuele Trovato  https://orcid.org/0000-0001-8301-9206 Elisa Cinotti  https://orcid.org/0000-0002-4009-0659 Michele Pellegrino  https://orcid.org/0000-0001-9330-8570 Pietro Rubegni  https://orcid.org/0000-0002-7762-9312 R E FE R E N C E S 1. Slominski RM, Tuckey RC, Manna PR, et al. Extra- adrenal glucocor-ticoid biosynthesis: implications for autoimmune and inflammatory disorders. Genes Immun. 2020;21(3):150- 168.394  |     LETTER TO THE EDITOR  2. Slominski AT, Michal AZ, Blazej Z, Desmond JT, Theoharis CT, Jean R. Key role of CRF in the skin stress response system. Endocr Rev. 2013;34(6):827- 884. 3. Tomlinson J, Walker E, Bujalska I, et al. 11β- Hydroxysteroid Dehydrogenase Type 1: a tissue- specific regulator of glucocorticoid responses. Endocr Rev. 2004;25:831- 866. 4. Tiganescu A, Walker EA, Hardy RS, Mayes AE, Stewart PM. Localization, age- and site- dependent expression, and regulation of 11β- hydroxysteroid dehydrogenase type 1 in skin. J Invest Dermatol. 2011;131(1):30- 36. 5. Tiganescu A, Tahrani AA, Morgan SA, et al. 11β- Hydroxysteroid dehydrogenase blockade prevents age- induced skin structure and function defects. J Clin Invest. 2013;123(7):3051- 3060. 6. Itoi S, Terao M, Murota H, Katayama I. 11β- Hydroxysteroid dehy-drogenase 1 contributes to the pro- inflammatory response of kera-tinocytes. Biochem Biophys Res Commun. 2013;440(2):265- 270. 7. Schmitt J, Wozel G. The psoriasis area and severity index is the ad-equate criterion to define severity in chronic plaque- type psoriasis. Dermatology. 2005;210(3):194- 199. 8. Tiala I, Suomela S, Huuhtanen J, et al. The CCHCR1 (HCR) gene is relevant for skin steroidogenesis and downregulated in cultured pso-riatic keratinocytes. J Mol Med (Berl). 2007;85(6):589- 601. 9. Skobowiat C, Sayre RM, Dowdy JC, Slominski AT. Ultraviolet radia-tion regulates cortisol activity in a waveband- dependent manner in human skin ex vivo. Br J Dermatol. 2013;168(3):595- 601. 10. Slominski AT, Zmijewski MA, Plonka PM, Szaflarski JP, Paus R. How UV light touches the brain and endocrine system through skin, and why. Endocrinology. 2018;159(5):1992- 2007. 11. Tiganescu A, Hupe M, Jiang YJ, et al. UVB induces epidermal 11β- hydroxysteroid dehydrogenase type 1 activity in vivo. Exp Dermatol. 2015;24(5):370- 376. 12. Tiganescu A, Hupe M, Uchida Y, Mauro T, Elias PM, Holleran WM. Topical 11β- Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice. Endocrinology. 2018;159(1):547- 556.SUPPORTING INFORMATIONAdditional supporting information may be found in the online ver-sion of the article at the publisher’s website.How to cite this article: Tognetti L, Damiani F, Marrocco C, et al. Evaluation of 11- β hydroxysteroid dehydrogenase type 1 in cutaneous fibroblasts cultures of psoriatic lesional skin before and after narrow band- UVB phototherapy. Photodermatol Photoimmunol Photomed. 2022;38:391– 394. doi:10.1111/phpp.12752

Evaluation of 11-β hydroxysteroid dehydrogenase type 1 in cutaneous fibroblasts cultures of psoriatic lesional skin before and after narrow band-UVB phototherapy

PubMed Central

Evaluation of 11‐β hydroxysteroid dehydrogenase type 1 in cutaneous fibroblasts cultures of psoriatic lesional skin before and after narrow band‐UVB phototherapy

Evaluation of 11-β hydroxysteroid dehydrogenase type 1 in cutaneous fibroblasts cultures of psoriatic lesional skin before and after narrow band-UVB phototherapy

Abstract

Similar works

Full text

Available Versions

Archivio della Ricerca - Università degli Studi di Siena

PubMed Central

Crossref